Cooperation with SLK Heilbronn
R&D cooperation with SLK Clinics Heilbronn to optimize the assessment of HCC therapies
Targeted therapy methods to treat hepatocellular carcinomas, such as chemoembolization (TACE) or internal radiation therapy (SIRT), are gaining importance in HCC treatment. In this context, criteria like RECIST or WHO provide only limited feasibility to monitor the effectiveness of therapy.
Mint Medical and the department of radiology at SLK Clinics Heilbronn, with its director Prof. Dr. Philippe Pereira, initiated an R&D collaboration to develop optimized and efficient solutions to assess the effectiveness of HCC treatment, such as the EASL criteria (European Association for the Study of the Liver).